beta-tricalcium phosphate

unit cells is 273 atoms compared with 312 for alpha-tricalcium phosphate; see also records for alpha-tricalcium phosphate, tricalcium phosphate; apatitic tricalcium phosphate Ca9(HPO4)(PO4)5(OH) is the calcium orthophosphate leading to beta-tricalcium phosphate Ca3(PO4)2

Also Known As:

Networked: 146 relevant articles (11 outcomes, 30 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Endo, Naoto: 3 articles (11/2012 - 01/2002)
2.	Ogose, Akira: 3 articles (11/2012 - 01/2002)
3.	McGuire, Michael K: 3 articles (04/2009 - 12/2005)
4.	Mellonig, James T: 3 articles (04/2009 - 12/2005)
5.	Hernigou, Philippe: 2 articles (01/2022 - 02/2010)
6.	Guan, Jian-Lei: 2 articles (05/2021 - 04/2020)
7.	Guo, Wan-Shou: 2 articles (05/2021 - 04/2020)
8.	Liu, Pei: 2 articles (05/2021 - 04/2020)
9.	Liu, Zhao-Hui: 2 articles (05/2021 - 04/2020)
10.	Mu, Xiao-Hong: 2 articles (05/2021 - 04/2020)

Related Diseases

1.	Gingival Recession 01/01/2013 - "The aim of this study was to investigate the effect of beta-tricalcium phosphate (β-TCP) particles in combination with acellular dermal matrix (ADM) allograft in gingival recession. " 01/01/2013 - "Coverage of gingival recession defects using acellular dermal matrix allograft with or without beta-tricalcium phosphate." 04/01/2009 - "CTG and rhPDGF-BB + beta-TCP + wound-healing dressing are effective treatment modalities for clinically correcting gingival recession defects. " 02/01/2009 - "Gingival recession defects were surgically created in six premolar teeth with no more than 3 mm of keratinized marginal tissue, an osseous crest 2 to 3 mm apical to the newly created gingival margin, and recession depth of at least 3 mm. The defects were left untouched for 2 months; then, four defects were grafted with rhPDGF-BB + beta-TCP + a wound healing dressing, and two defects received CTGs. " 12/01/2005 - "Treatment with rhPDGF-BB stimulated a significant increase in the rate of CAL gain, reduced gingival recession at 3 months post-surgery, and improved bone fill as compared to a beta-TCP bone substitute at 6 months."
2.	Scoliosis 02/01/2009 - "A level-1 pilot study to evaluate of ultraporous beta-tricalcium phosphate as a graft extender in the posterior correction of adolescent idiopathic scoliosis." 01/01/2008 - "beta-Tricalcium phosphate, which is used to augment autograft fusions addressing idiopathic scoliosis or lumbar disease, also proved to be effective. " 10/01/2001 - "The aim of this study is to evaluate the ability of beta-tricalcium phosphate (TCP) in granular form to achieve dorsal spondylodesis in adolescent idiopathic scoliosis (AIS). " 02/01/2009 - "The promising early results of this pilot study support that beta-TCP appears to be an effective bone substitute in scoliosis surgery avoiding harvesting of pelvic bone and the associated morbidity." 01/01/2010 - "A Medline search was conducted via PubMed by use of the following terms in various combinations: lumbar fusion, freeze-dried allograft, fresh-frozen allograft, autograft, iliac crest, demineralized bone matrix, rhBMP-2, rhBMP-7, scoliosis, bone marrow aspirate, HEALOS, coralline hydroxyapatite, beta tricalcium phosphate, synthetic, ceramics, spinal fusion, PLF, PLIF, ALIF, and TLIF. "
3.	Spinal Cord Diseases 05/01/2008 - "The objective of this prospective, randomized clinical study was to evaluate the effectiveness of implanting interbody fusion cage containing beta-TCP for the treatment of cervical radiculopathy and/or myelopathy, and the fusion rates and outcomes in patients with or without randomly assigned plate fixation. " 05/01/2008 - "Based on the findings of this study, interbody fusion cage containing beta-TCP following one- or two-level discectomy proved to be an effective treatment for cervical spondylotic radiculopathy and/or myelopathy. " 05/01/2008 - "Sixty-two patients with cervical radiculopathy and/or myelopathy due to soft disc herniation or spondylosis were treated with one- or two-level discectomy and fusion with interbody cages containing beta-TCP. "
4.	Radiculopathy (Radiculopathy, Cervical) 05/01/2008 - "The objective of this prospective, randomized clinical study was to evaluate the effectiveness of implanting interbody fusion cage containing beta-TCP for the treatment of cervical radiculopathy and/or myelopathy, and the fusion rates and outcomes in patients with or without randomly assigned plate fixation. " 05/01/2008 - "Based on the findings of this study, interbody fusion cage containing beta-TCP following one- or two-level discectomy proved to be an effective treatment for cervical spondylotic radiculopathy and/or myelopathy. " 05/01/2008 - "Sixty-two patients with cervical radiculopathy and/or myelopathy due to soft disc herniation or spondylosis were treated with one- or two-level discectomy and fusion with interbody cages containing beta-TCP. "
5.	Osteoporosis 06/01/2004 - "The purpose of this study was to evaluate the efficacy of zinc (Zn)-containing beta-tricalcium phosphate (Zn-TCP) in correcting the bone mineral deficiency noted in osteoporosis using ovariectomized rat model. "

Related Drugs and Biologics

1.	beta-tricalcium phosphate
2.	Becaplermin (PDGF-BB)
3.	Bone Substitutes
4.	Collagen
5.	Minerals
6.	Zinc
7.	Tuberculin (PPD)
8.	Durapatite (Hydroxylapatite)
9.	calcium phosphate
10.	Platelet-Derived Growth Factor

Related Therapies and Procedures

1.	Diskectomy (Discectomy)
2.	Therapeutics
3.	Curettage
4.	Transplantation
5.	Spinal Fusion (Spondylosyndesis)